Travere Therapeutics, Inc. · NASDAQ:TVTX

Baynes Roy D. sold 10,000 Travere Therapeutics, Inc. shares (Form 4)

Traded Apr 6, 2026 · Filed Apr 7, 2026

On Apr 6, 2026, Baynes Roy D. (Director) sold 10,000 Travere Therapeutics, Inc. shares at US$33.00 for US$330K under a trading plan, leaving 37,500 shares. Filed Apr 7, 2026 (Form 4).

Sold
10,000 shares
Price
US$33.00
Value
US$330K
Holding after
37,500 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 6, 2026Common StockOption exercise10,000US$26.5247,500Direct
Apr 6, 2026Common StockSale10,000US$33.0037,500Direct

Source

View original at SEC

Related